Targeting TAK1 to overcome cisplatin resistance in lung adenocarcinoma by rewiring the NF-κB and p53 signaling
sciencedirect.com/science/article/pii/S000629...Posted Jul 30, 2026, 2:17 PM UTC
10
sciencedirect.com
Loading comments…
Posted Jul 30, 2026, 2:17 PM UTC